NYC Files Antitrust Suit Vs. Glaxo Over Paxil Patents
The City of New York has filed a lawsuit against U.K. drug maker GlaxoSmithKline PLC, claiming that the company engaged in "anticompetitive, fraudulent, and inequitable conduct" when it acquired patents for...To view the full article, register now.
Already a subscriber? Click here to view full article